Cargando…

Malignant soft tissue sarcoma of the shoulder treated by surface mould brachytherapy boost in an adjuvant setting

PURPOSE: Soft tissue sarcomas of the extremities account for half of all soft tissue sarcomas. Radiotherapy and surgery have been the standard modalities in the treatment of this type of cancer. Brachytherapy can be used as the sole therapy, if the target volume is localized and easily accessible. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Mukherji, Ashutosh, Sinnatamby, Mourougan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437085/
https://www.ncbi.nlm.nih.gov/pubmed/28533807
http://dx.doi.org/10.5114/jcb.2017.67392
_version_ 1783237521528848384
author Mukherji, Ashutosh
Sinnatamby, Mourougan
author_facet Mukherji, Ashutosh
Sinnatamby, Mourougan
author_sort Mukherji, Ashutosh
collection PubMed
description PURPOSE: Soft tissue sarcomas of the extremities account for half of all soft tissue sarcomas. Radiotherapy and surgery have been the standard modalities in the treatment of this type of cancer. Brachytherapy can be used as the sole therapy, if the target volume is localized and easily accessible. This work reports three cases of shoulder soft tissue sarcomas with positive deep resected margins, treated with a combination of external beam radiotherapy and surface mould brachytherapy boost technique. MATERIAL AND METHODS: Between January and June 2014, three patients received brachytherapy with sites close to the shoulder, and post-surgery involved deep resected margins. Each mould was made on a base of thermoplastic, over which dental wax was coated and catheters implanted. The target volume was defined as the tissue covering the tumor bed with lateral margins of 2-2.5 cm and depth of 1-1.5 cm. Treatment planning was computed tomography-based and dose prescribed was 85-100% isodose. Treatments has been delivered twice daily, six hours interval, and a review of reactions evaluated. RESULTS: Volume receiving more than 150% of the prescribed dose has been limited to less than 2%, and that above 200% to be inside the mould. Brachytherapy equivalent dose at 2 Gy per fraction (EQD(2)) of these patients was 24 and 28.6 Gy. Maximum dose to organ at risk (OAR) (2 cc of OAR) ranged between 55-87% of prescribed dose, with a median dose being 80%. All cases had only grade 1 post-radiotherapy skin immediate reactions, which resolved within four weeks. In all patients, no treatment failures were noted at nearly 2-years post-irradiation. CONCLUSIONS: Surface mould brachytherapy in soft tissue sarcomas could be a useful alternative to interstitial brachytherapy, especially where the target volume is superficially extensive with underlying critical structures, and where catheter placement may be difficult, such as the shoulder.
format Online
Article
Text
id pubmed-5437085
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-54370852017-05-22 Malignant soft tissue sarcoma of the shoulder treated by surface mould brachytherapy boost in an adjuvant setting Mukherji, Ashutosh Sinnatamby, Mourougan J Contemp Brachytherapy Case Report PURPOSE: Soft tissue sarcomas of the extremities account for half of all soft tissue sarcomas. Radiotherapy and surgery have been the standard modalities in the treatment of this type of cancer. Brachytherapy can be used as the sole therapy, if the target volume is localized and easily accessible. This work reports three cases of shoulder soft tissue sarcomas with positive deep resected margins, treated with a combination of external beam radiotherapy and surface mould brachytherapy boost technique. MATERIAL AND METHODS: Between January and June 2014, three patients received brachytherapy with sites close to the shoulder, and post-surgery involved deep resected margins. Each mould was made on a base of thermoplastic, over which dental wax was coated and catheters implanted. The target volume was defined as the tissue covering the tumor bed with lateral margins of 2-2.5 cm and depth of 1-1.5 cm. Treatment planning was computed tomography-based and dose prescribed was 85-100% isodose. Treatments has been delivered twice daily, six hours interval, and a review of reactions evaluated. RESULTS: Volume receiving more than 150% of the prescribed dose has been limited to less than 2%, and that above 200% to be inside the mould. Brachytherapy equivalent dose at 2 Gy per fraction (EQD(2)) of these patients was 24 and 28.6 Gy. Maximum dose to organ at risk (OAR) (2 cc of OAR) ranged between 55-87% of prescribed dose, with a median dose being 80%. All cases had only grade 1 post-radiotherapy skin immediate reactions, which resolved within four weeks. In all patients, no treatment failures were noted at nearly 2-years post-irradiation. CONCLUSIONS: Surface mould brachytherapy in soft tissue sarcomas could be a useful alternative to interstitial brachytherapy, especially where the target volume is superficially extensive with underlying critical structures, and where catheter placement may be difficult, such as the shoulder. Termedia Publishing House 2017-04-26 2017-04 /pmc/articles/PMC5437085/ /pubmed/28533807 http://dx.doi.org/10.5114/jcb.2017.67392 Text en Copyright: © 2017 Termedia Sp. z o. o. http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Case Report
Mukherji, Ashutosh
Sinnatamby, Mourougan
Malignant soft tissue sarcoma of the shoulder treated by surface mould brachytherapy boost in an adjuvant setting
title Malignant soft tissue sarcoma of the shoulder treated by surface mould brachytherapy boost in an adjuvant setting
title_full Malignant soft tissue sarcoma of the shoulder treated by surface mould brachytherapy boost in an adjuvant setting
title_fullStr Malignant soft tissue sarcoma of the shoulder treated by surface mould brachytherapy boost in an adjuvant setting
title_full_unstemmed Malignant soft tissue sarcoma of the shoulder treated by surface mould brachytherapy boost in an adjuvant setting
title_short Malignant soft tissue sarcoma of the shoulder treated by surface mould brachytherapy boost in an adjuvant setting
title_sort malignant soft tissue sarcoma of the shoulder treated by surface mould brachytherapy boost in an adjuvant setting
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437085/
https://www.ncbi.nlm.nih.gov/pubmed/28533807
http://dx.doi.org/10.5114/jcb.2017.67392
work_keys_str_mv AT mukherjiashutosh malignantsofttissuesarcomaoftheshouldertreatedbysurfacemouldbrachytherapyboostinanadjuvantsetting
AT sinnatambymourougan malignantsofttissuesarcomaoftheshouldertreatedbysurfacemouldbrachytherapyboostinanadjuvantsetting